Dabur Pharma receives USFDA approval for marketing Novantrone
New Delhi, May 21 (UNI) Dabur Pharma Ltd today said it has received the final approval to market its generic version of EMD Serono's Novantrone (Mitoxantrone Hydrochloride) Injection 20 mg, 25 mg and 30 mg.
The firm's Abbreviated New Drug Application (ANDA) has received US Food and Drug Administration (USFDA) final approval to market the generic version of EMD Serono's Novantrone injection 20 mg, 25 mg and 30 mg, a company statement said.
It is used for the treatment of secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis.
UNI SR AK AS1303
More From
-
Bangalore Gold Silver Rate Today, March 9, 2026: Gold and Silver Prices Fall as US Dollar Strengthens -
Vijay-NDA Alliance On Cards? Pawan Kalyan Reportedly Reaches Out to TVK Chief -
Who Was Mojtaba Khamenei’s Wife Zahra Haddad-Adel and What Do We Know About Her? -
Who Is Aditi Hundia? Viral ‘Girl in Red’ & Ishan Kishan's Girlfriend Spotted During IND vs NZ Final -
Hyderabad Gold Silver Rate Today, 9 March 2026: Latest 24K, 22K Gold And Silver Rates In City -
Kerala Election 2026 Date: When Can You Expect EC To Announce Key Dates of Voting & Counting? -
Chennai MRTS Velachery–St Thomas Mount Line Opening on March 10 Faces Delay; Direct Beach Route to Start Later -
Mumbai Water Supply Cut For 24 Hours: Check Dates, Timings & Areas Affected by BMC Maintenance Disruption -
Hardik Pandya and Girlfriend Mahieka Sharma’s Celebration Video Goes Viral After India’s Win -
Bengaluru Hotels to Shut From Tomorrow March 10 as Commercial LPG Supply Stops -
Trisha's Net Worth: How Rich Is Thalapathy Vijay's Rumoured Girlfriend? -
Pune Electrician Arrested After Viral Video Shows Him Raising ‘Pakistan Zindabad’ Slogans, Watch
Click it and Unblock the Notifications
Sign in with Google